Because IL-17A, a well-known pro-inflammatory factor in COPD patients, can promote the infiltration of inflammatory cells in the lung parenchyma and airways, the role of IL-17A in regulating the progression of COPD should be further explored. This evidence concerns the gene IL17A and chronic obstructive pulmonary disease.